Cambridge Investment Research Advisors
SZYM

Cambridge Investment Research Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-58,005
Closed -$433K – 1536
2014
Q3 		$433K Buy
58,005
+10,200
+21% +$95.3K 0.01% 898
2014
Q2 		$563K Buy
47,805
+10,000
+26% +$107K 0.02% 694
2014
Q1 		$439K Buy
37,805
+2,330
+7% +$27.4K 0.02% 773
2013
Q4 		$386K Buy
35,475
+9,800
+38% +$96.4K 0.02% 764
2013
Q3 		$277K Buy
+25,675
New +$292K 0.01% 877

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cambridge Investment Research Advisors's SZYM Position: Q4 2014 in Review

Cambridge Investment Research Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q4 2014, closing a stake of 58,005 shares — an estimated $433K sold.

Cambridge Investment Research Advisors first reported a position in SZYM in Q3 2013 and held it in 5 quarters. The position peaked at $563K in Q2 2014. 114 funds tracked by Wall St. Rank hold SZYM as of Q4 2014.

  • Cambridge Investment Research Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 58,005 SOLAZYME INC COM STK (DE) shares in Q4 2014, an estimated $433K.
  • Cambridge Investment Research Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q3 2013 and held it in 5 quarters.
  • Cambridge Investment Research Advisors's SOLAZYME INC COM STK (DE) position peaked at $563K in Q2 2014.
  • 114 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q4 2014.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2014, filed 6 Feb 2015.